av/tme-pharma-nv--big.svg

COM:TMEPHARMA

TME Pharma N.V.

  • Stock

EUR

Last Close

0.15

25/11 09:23

Market Cap

6.05M

Beta: -

Volume Today

744.63K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.01
-
0.01
12.02%
0.03
306.43%
cash conversion cycle
-228.24
-
946.90
514.88%
-355.74
137.57%
cash per share
76.15
-
212.04
178.45%
148.11
30.15%
32.49
78.06%
108.52
233.97%
12.41
88.56%
31.93
157.24%
14.37
54.99%
3.57
75.16%
company equity multiplier
-0.49
-
-0.86
73.57%
-1.16
34.66%
-0.24
79.47%
-1.74
632.87%
-0.94
46.00%
1.38
247.04%
2.16
56.56%
-4.12
290.45%
days of inventory outstanding
3.77
-
1.80
52.37%
38.66
-
863.25
2,132.72%
685.76
20.56%
293.59
57.19%
days of payables outstanding
246.61
-
438.50
77.81%
355.74
18.87%
484.51
36.20%
511.07
5.48%
424.24
16.99%
10.45K
2,362.29%
12.36K
18.33%
6.72K
45.59%
days of sales outstanding
14.60
-
1.38K
9,376.74%
dividend yield
ebit per revenue
-526.64
-
-344.88
34.51%
-103.60
69.96%
ebt per ebit
1.05
-
1.09
3.77%
1.25
14.71%
1.14
8.65%
2.46
115.80%
0.22
91.14%
1.80
728.06%
1.09
39.61%
1.26
15.44%
effective tax rate
-0.00
-
0.00
727.41%
-0.00
284.51%
-0.00
92.63%
-0.00
49.81%
-0.00
1,148.49%
-0.04
3,346.28%
-0.00
99.83%
-0.00
568.81%
enterprise value multiple
-3.72
-
-3.40
8.65%
-4.45
31.04%
-4.14
6.92%
-1.15
72.21%
-6.45
459.96%
-1.50
76.68%
-0.65
56.50%
-0.09
86.39%
fixed asset turnover
0.03
-
0.07
120.21%
1.24
1,637.21%
free cash flow per share
-623.65
-
-672.72
7.87%
-562.48
16.39%
-199.62
64.51%
-100.75
49.53%
-38.55
61.73%
-16.26
57.81%
-18.78
15.49%
-9.37
50.10%
gross profit margin
-146.12
-
-60.44
58.64%
-16.58
72.57%
interest coverage
-20.83
-
-11.46
44.99%
-4.04
64.72%
-2.82
30.27%
-0.65
77.08%
-1.32K
203,553.03%
-1.14
99.91%
-8.82
672.94%
-3.54
59.89%
-3.72
5.03%
inventory turnover
96.79
-
203.23
109.97%
9.44
-
0.42
95.52%
0.53
25.88%
1.24
133.58%
long term debt to capitalization
-1.99
-
-8.46
326.27%
-0.31
-
-0.03
88.91%
-0.04
12.17%
0.00
106.98%
-0.06
-
net income per ebt
1.00
-
1.00
0.16%
1.00
0.34%
1.00
0.28%
1.00
0.05%
1.00
0.14%
1.00
0.13%
1
0.01%
1.00
0.04%
net profit margin
-551.92
-
-374.47
32.15%
-129.48
65.42%
operating cash flow per share
-621.30
-
-672.32
8.21%
-561.17
16.53%
-199.53
64.44%
-100.53
49.62%
-38.41
61.79%
-16.14
57.97%
-18.76
16.22%
-9.36
50.13%
operating cycle
18.37
-
1.39K
7,441.21%
operating profit margin
-526.64
-
-344.88
34.51%
-103.60
69.96%
payables turnover
1.48
-
0.83
43.76%
1.03
23.26%
0.75
26.58%
0.71
5.20%
0.86
20.47%
0.03
95.94%
0.03
15.49%
0.05
83.80%
pretax profit margin
-551.80
-
-374.98
32.04%
-129.22
65.54%
price fair value
-6.91
-
-6.13
11.22%
-14.21
131.71%
-3.39
76.12%
-1.56
53.92%
-3.52
125.39%
2.36
166.94%
3.42
44.99%
-1.24
136.40%
receivables turnover
25
-
0.26
98.94%
return on assets
-4.47
-
-2.67
40.31%
-3.75
40.54%
-5.80
54.74%
-2.38
59.01%
-0.50
79.08%
-0.98
96.46%
-1.48
51.49%
-2.89
95.15%
return on capital employed
6.31
-
19.99
216.82%
3.46
82.67%
1.58
54.29%
1.73
9.44%
2.23
28.71%
-0.74
133.34%
-2.95
296.24%
9.98
438.75%
return on equity
2.21
-
2.29
3.60%
4.33
89.25%
1.38
68.23%
4.13
200.38%
0.47
88.70%
-1.35
388.87%
-3.20
137.18%
11.90
471.65%
total debt to capitalization
83.14
-
4.81
94.22%
6.38
32.76%
-1.99
131.24%
2.18
209.62%
-0.07
103.02%
0.01
113.45%
0.35
3,855.19%
1.45
313.89%

All numbers in EUR (except ratios and percentages)